Skip to content

About Us

Our Mission

At Torch Bio, we illuminate the path to safer, more effective drug discovery. Our mission is to revolutionize pharmaceutical development by harnessing cutting-edge technologies, including patient-derived iPSC liver organoids and advanced AI models. We are committed to:

  1. Accelerating drug discovery through innovative high-content screening assays across multiple therapeutic areas.
  2. Enhancing drug safety prediction with state-of-the-art AI models, particularly focusing on drug-induced liver injury and liver diseases.
  3. Providing comprehensive drug profiling services that evaluate both efficacy and safety in complex biological systems.
  4. Empowering researchers and pharmaceutical companies with our AI/ML platform to streamline the selection of compounds with the highest therapeutic potential.

Through our expertise and dedication to scientific excellence, we strive to transform the drug development process, ultimately improving patient outcomes and advancing global healthcare.

Jonny Sexton, PhD

Co-Founder

Jesse Wotring, PhD

Co-Founder, CEO

Joel Yates, PhD

CSO